Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Subhajit Karmakar
Institutions:
Indian Institute of Chemical Biology,
Council of Scientific and Industrial Research,
Academy of Scientific and Innovative Research
Observed institutions:
Indian Institute of Chemical Biology,
Council of Scientific and Industrial Research,
Academy of Scientific and Innovative Research
ORCID:
0000-0001-5112-9857
Observed ORCID:
0000-0001-5112-9857
OpenAlex ID:
A5109533036
MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives
2024
·
Rajni Shaw
, Malini Basu
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
·
85
USP7 imparts partial EMT state in colorectal cancer by stabilizing the RNA helicase DDX3X and augmenting Wnt/β-catenin signaling
2023
·
Bhaskar Basu
, Subhajit Karmakar
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
·
31
Wnt/β-catenin signaling and p68 conjointly regulate CHIP in colorectal carcinoma
2021
·
Satadeepa Kal
, Shrabastee Chakraborty
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
·
21
Neurological damages in COVID‐19 patients: Mechanisms and preventive interventions
2023
·
Sibani Sarkar
, Subhajit Karmakar
, et al.
·
MedComm
·
17
PDF
The E3 ubiquitin ligase CHIP drives monoubiquitylation-mediated nuclear import of the tumor suppressor PTEN
2023
·
Shrabastee Chakraborty
, Subhajit Karmakar
, et al.
·
Journal of Cell Science
·
9
PDF
DDX5 (p68) orchestrates β-catenin, RelA and SP1 mediated MGMT gene expression in human colon cancer cells: Implication in TMZ chemoresistance
2023
·
Rajni Shaw
, Subhajit Karmakar
, et al.
·
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
·
7
PDF
CK2: The master regulator in tumor immune-microenvironment - A crucial target in oncotherapy
2025
·
Subhajit Karmakar
, Mouli Chatterjee
, et al.
·
European Journal of Pharmacology
·
5
E3 ubiquitin ligases in lung cancer: Emerging insights and therapeutic opportunities
2023
·
Bhaskar Basu
, Satadeepa Kal
, et al.
·
Life Sciences
·
5
STUB1 (CHIP) – a prognostic marker in cancer
2025
·
Subhajit Karmakar
, Mouli Chatterjee
, et al.
·
Molecular Omics
·
2
The Nuclear Face of PTEN : Implications in Cancer Prognosis and Targeted Therapy
2026
·
Mrinal K. Ghosh
, Shrabastee Chakraborty
, et al.
·
BioFactors
·
1
PDF
The Role of Extracellular Vesicles in the Progression of Tumors towards Metastasis
2021
·
Bhaskar Basu
, Subhajit Karmakar
·
Physiology
·
1
Corrigendum: “CK2: The master regulator in tumor immune-microenvironment - A crucial target in oncotherapy” [10.1016/j.ejphar.2025.177376]
2026
·
Subhajit Karmakar
, Mouli Chatterjee
, et al.
·
European Journal of Pharmacology
Advancements in Hematopoietic Cancer Treatment
2026
·
Subhajit Karmakar
, Mouli Chatterjee
, et al.
·
Springer eBooks
Author response for "STUB1(CHIP) - A Prognostic Marker in Cancer"
2025
·
Subhajit Karmakar
, Mouli Chatterjee
, et al.
·
Publons reviews and discussion
CK2α phosphorylates CHIP for oncogenesis: A novel post-translational switch in cancer
2025
·
Subhajit Karmakar
, Mouli Chatterjee
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Adjuvants and Neoadjuvant Therapies in the Treatment of Colorectal Cancer
2025
·
Subhajit Karmakar
, Atharva Anand Mahajan
, et al.
·
CRC Press eBooks
Show more works
View as search
Works count:
16
Citation count:
184
H-index:
6
I10-index:
4
Year
Topic
Type